Planta Med 2011; 77(3): 252-256
DOI: 10.1055/s-0030-1250221
Biological and Pharmacological Activity
Letters
© Georg Thieme Verlag KG Stuttgart · New York

Suppression of Intracellular Calcium Levels and Inhibition of Degranulation in RBL-2H3 Mast Cells by the Sesquiterpene Lactone Parthenolide

JangJa Hong1 , 2 , Suzue Aoyama3 , Noriyasu Hirasawa3 , OkPyo Zee2 , Kenji Ishihara4 , Chika Hashida1 , Michio Kimura1 , Toshio Seyama1 , Kazuo Ohuchi1
  • 1Laboratory of Life Sciences, Faculty of Pharmacy, Yasuda Women's University, Hiroshima, Japan
  • 2Laboratory of Pharmacognosy, Graduate School of Pharmacy, Sungkyunkwan University, Suwon, Kyungi-do, Korea
  • 3Laboratory of Pharmacotherapy of Life-style Related Diseases, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan
  • 4Laboratory of Medical Science, Faculty of Education, Ibaraki University, Mito, Japan
Further Information

Publication History

received January 26, 2010 revised June 30, 2010

accepted July 7, 2010

Publication Date:
02 September 2010 (online)

Abstract

Pretreatment with parthenolide for 60 min inhibited the antigen-induced degranulation of RBL-2H3 mast cells; the IC50 value being 4.5 ± 0.4 µM. The inhibition was not due to suppression of the phosphatidylinositol 3-kinase pathway because the antigen-induced phosphorylation of Akt was not inhibited by parthenolide. The antigen-induced increase in intracellular calcium levels was prevented by parthenolide, suggesting that parthenolide inhibited the antigen-induced degranulation by suppressing an increase in intracellular calcium levels. In support of this, parthenolide was found to prevent ionomycin-induced degranulation by inhibiting an increase in intracellular calcium levels. Therefore, parthenolide inhibits the degranulation of mast cells by preventing an increase in intracellular calcium levels.

References

  • 1 Aoyama S, Hong J, Ishihara K, Lee X M, Oh J S, Kwak J H, Zee O, Ohuchi K. Inhibition of mast cell degranulation by the NF-κB inhibitor parthenolide. Abstract No. 3, 126th Annual Meeting of Pharmaceutical Society of Japan, Sendai, Japan; 2006: 5. 
  • 2 Schinella G R, Giner R M, Recio M C, Mordujovich de Buschiazzo P, Ríos J L, Máñez S. Anti-inflammatory effects of South American Tanacetum vulgare.  J Pharm Pharmacol. 1998;  50 1069-1074
  • 3 Jain N K, Kulkarni S K. Antinociceptive and anti-inflammatory effects of Tanacetum parthenium L. extract in mice and rats.  J Ethnopharmacol. 1999;  68 251-259
  • 4 Felteistein M E, Schühlkly W, Warnick J E, Fischer N H, Sufka K J. Anti-inflammatory and anti-hyperalgesic effects of sesquiterpene lactones from Magnolia and Bear's foot.  Pharmacol Biochem Behav. 2004;  79 299-302
  • 5 López-Franco O, Suzuki Y, Sanjuán G, Blanco J, Hernández-Vargas P, Yo Y, Kopp J, Egido J, Gómez-Guerrero C. Nuclear factor-κB inhibitors as potential novel anti-inflammatory agents for the treatment of immune glomerulonephritis.  Am J Pathol. 2002;  161 1497-1505
  • 6 Tournier H, Schinella G, de Balsa E M, Buschiazzo H, Mañez S, Mordujovich de Buschiazzo P. Effect of the chloroform extract of Tanacetum vulgare and one of its active principles, parthenolide, on experimental gastric ulcer in rats.  J Pharm Pharmacol. 1999;  51 215-219
  • 7 Reuter U, Chiarugi A, Bolay H, Moskowitz M A. Nuclear factor-κB as a molecular target for migraine therapy.  Ann Neurol. 2002;  51 507-516
  • 8 Zingarelli B, Hake P W, Denenberg A, Wong H R. Sesquiterpene lactone parthenolide, an inhibitor of IκB kinase complex and nuclear factor-κB, exerts beneficial effects in myocardial reperfusion injury.  Shock. 2002;  17 127-134
  • 9 Kiuchi H, Takao T, Yamamoto K, Nakayama J, Miyagawa Y, Tsujimura A, Nonomura N, Okuyama A. Sesquiterpene lactone parthenolide ameliorates bladder inflammation and bladder overactivity in cyclophosphamide induced rat cystitis model by inhibiting nuclear factor-κB phosphorylation.  J Urol. 2009;  181 1987-1988
  • 10 Hehner S P, Hofmann T G, Dröge W, Schmitz M L. The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-κB by targeting the IκB kinase complex.  J Immunol. 1999;  163 5617-5623
  • 11 Uchi H, Arrighi J F, Aubry J P, Furue M, Hauser C. The sesquiterpene lactone parthenolide inhibits LPS- but not TNF-α -induced maturation of human monocyte-derived dendritic cells by inhibition of the p38 mitogen-activated protein kinase pathway.  J Allergy Clin Immunol. 2002;  110 269-276
  • 12 Fiebich B L, Lieb K, Engels S, Heinrich M. Inhibition of LPS-induced p42/44 MAP kinase activation and iNOS/NO synthesis by parthenolide in rat primary microglial cells.  J Neuroimmunol. 2002;  132 18-24
  • 13 Ching T T, Hsu A L, Johnson A J, Chen C S. Phosphoinositide 3-kinase facilitates antigen-stimulated Ca2+ influx in RBL-2H3 mast cells via a phosphatidylinositol 3,4,5-trisphosphate-sensitive Ca2+entry mechanism.  J Biol Chem. 2001;  276 14814-14820
  • 14 Miyata N, Gon Y, Nunomura S, Endo D, Yamashita K, Matsumoto K, Hashimoto S, Ra C. Inhibitory effects of parthenolide on antigen-induced microtubule formation and degranulation in mast cells.  Int Immunopharmacol. 2008;  8 874-880
  • 15 Wang P, Xu S, Zhao K, Xiao B, Guo J. Increase in cytosolic calcium maintains plasma membrane integrity through the formation of microtubule ring structure in apoptotic cervical cancer cells induced by trichostatin.  Cell Biol Int. 2009;  33 1149-1154
  • 16 Bischoff S C. Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data.  Nat Rev Immunol. 2007;  7 93-104
  • 17 Hong J, Sasaki H, Hirasawa N, Ishihara K, Kwak J H, Zee O, Schmitz F J, Seyama T, Ohuchi K. Suppression of the antigen-stimulated RBL-2H3 mast cell activation by artekeiskeanol A.  Planta Med. 2009;  75 1494-1498

JangJa Hong, PhD

Laboratory of Life Sciences
Faculty of Pharmacy
Yasuda Women's University

6-13-1 Yasuhigashi

Asaminami-ku

731-0153 Hiroshima

Japan

Phone: +81 8 28 78 94 51

Fax: +81 8 28 78 28 96

Email: ohuchi-k@mail.pharm.tohoku.ac.jp

>